Filing Details
- Accession Number:
- 0001140361-12-046573
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-09 20:16:01
- Reporting Period:
- 2012-11-07
- Filing Date:
- 2012-11-09
- Accepted Time:
- 2012-11-09 20:16:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221590 | Jacques Jean Bienaime | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-11-07 | 2,000 | $47.73 | 172,691 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-07 | 3,000 | $47.00 | 169,691 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-09 | 2,000 | $48.42 | 167,691 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price in Column 4 is a weighted average price. The prices actually received ranged from $47.731 to $47.736. The reporting person will provide to the issue, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $47.001 to $47.062. The reporting person will provide to the issue, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $48.401 to $48.45. The reporting person will provide to the issue, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Billionaire Hedge Funds
